Stock 300841 CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chengdu Kanghua Biological Products Co., Ltd.

Equities

300841

CNE100003Y57

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 03/07/2024 am IST 		5-day change 1st Jan Change
52.06 CNY +1.22% Intraday chart for Chengdu Kanghua Biological Products Co., Ltd. -1.40% -32.86%
16/06 Certain A Shares of Chengdu Kanghua Biological Products Co., Ltd. are subject to a Lock-Up Agreement Ending on 16-JUN-2024. CI
23/04 Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Chengdu Kanghua Biological Products Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of vaccine products. The Company's main products are Rabies Vaccine (human diploid cell) for Human Use, Freeze-dried and Group ACYW135 Meningococcal Polysaccharide Vaccine. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 672

Sales per Business

CNY in Million2022Weight2023Weight Delta
Non-immune Planning Vaccine
100.0 %
- - 1,577 100.0 % -
Veterinary Vaccine
0.0 %
4 0.3 % 0 0.0 % -87.85%
Others
0.0 %
0 0.0 % 0 0.0 % -99.30%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.9 %
1,446 99.9 % 1,575 99.9 % +8.97%
Overseas
0.1 %
1 0.1 % 2 0.1 % +157.94%

Managers

Managers TitleAgeSince
Qing Han Wang CEO
 Chief Executive Officer 50 01/17/01
Wen Nian Wu DFI
 Director of Finance/CFO 41 01/10/01
Wen Li Hou BRD
 Director/Board Member 41 01/17/01
Hao Lu IRO
 Public Communications Contact 39 16/21/16

Members of the board

Members of the board TitleAgeSince
Xiao Bo Fang BRD
 Director/Board Member 50 01/20/01
Zhen Tao Wang CHM
 Chairman 59 -
Xiong Ping Yu BRD
 Director/Board Member 48 01/17/01
Bing Hui Zhang BRD
 Director/Board Member 61 16/18/16
Hai Ying Tao BRD
 Director/Board Member 50 16/21/16
Qing Han Wang CEO
 Chief Executive Officer 50 01/17/01
Wen Li Hou BRD
 Director/Board Member 41 01/17/01
Shu Qing Wu CHM
 Chairman 37 16/18/16
Xiao Wen Li BRD
 Director/Board Member 39 -
Qiang Wei Zhang BRD
 Director/Board Member 35 10/21/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 134,650,449 85,455,588 ( 63.46 %) 901,775 ( 0.6697 %) 63.46 %

Shareholders

NameEquities%Valuation
Yingke Innovation Asset Management Co. Ltd.
13.70 %
12,538,692 13.70 % 100 M ¥
Zhong Geng Fund Management Co. , Ltd.
11.41 %
10,438,537 11.41 % 83 M ¥
Yong Cai
7.308 %
6,687,422 7.308 % 53 M ¥
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
0.9855 %
901,775 0.9855 % 7 M ¥
Guotai Asset Management Co., Ltd.
0.7014 %
641,850 0.7014 % 5 M ¥
HuaAn Fund Management Co., Ltd.
0.6620 %
605,800 0.6620 % 5 M ¥
Taiping Fund Management Co., Ltd.
0.4746 %
434,319 0.4746 % 3 M ¥
Wanjia Asset Management Co., Ltd.
0.3592 %
328,699 0.3592 % 3 M ¥
Bosera Asset Management Co., Ltd.
0.2524 %
231,000 0.2524 % 2 M ¥
Fullgoal Fund Management Co., Ltd.
0.2346 %
214,685 0.2346 % 2 M ¥
NameEquities%Valuation
Zhen Tao Wang
70.26 %
30,310,155 70.26 % 242 M ¥
Qing Han Wang
2.980 %
1,285,678 2.980 % 10 M ¥
Sheng You Li
0.8086 %
348,848 0.8086 % 3 M ¥
Huai Gong Chen
0.5007 %
215,993 0.5007 % 2 M ¥
Ming Tai Tang
0.5007 %
215,992 0.5007 % 2 M ¥
Wen Nian Wu
0.3940 %
169,982 0.3940 % 1 M ¥
Wen Li Hou
0.3004 %
129,595 0.3004 % 1 M ¥
Wan Feng Sun
0.3004 %
129,595 0.3004 % 1 M ¥
Xiao Wen Li
0.0904 %
38,985 0.0904 % 311 600 ¥

Holdings

NameEquities%Valuation
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
0.99%
 901,775 0.99% 7,207,725 $

Company contact information

Chengdu Kanghua Biological Products Co., Ltd.

182 Beijing Road Economic & Technological Dev Zone

610100, Chengdu

+

http://www.kangh.com
address Chengdu Kanghua Biological Products Co., Ltd.(300841)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Chengdu Kanghua Biological Products Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
52.06 CNY
Average target price
81.68 CNY
Spread / Average Target
+56.89%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD. Stock Chengdu Kanghua Biological Products Co., Ltd.
-32.86% 938M
CSL LIMITED Stock CSL Limited
+3.92% 93.97B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+6.58% 41.61B
BIOGEN INC. Stock Biogen Inc.
-13.20% 33.32B
UCB Stock UCB
+77.12% 28.8B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.02% 15.61B
INCYTE CORPORATION Stock Incyte Corporation
-8.17% 13.27B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.49% 11.46B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+162.44% 10.06B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-54.92% 9.09B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300841 Stock
  4. Company Chengdu Kanghua Biological Products Co., Ltd.